MR

Mohandas Ramakrishnan Kakkanat

Director Director DIN 02053337
DIN 02053337 First appointment Apr 2008 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Apr 2008
Shareholding value β€’β€’β€’β€’ Premium profile

About Mohandas Ramakrishnan Kakkanat

Data last updated:

Mohandas Ramakrishnan Kakkanat was a Director at Robins Remedies Private Limited (2009–2016) and Director at Walden Pharmaceuticals Private Limited (from 2008). The companies operate in Pharma.

DIN 02053337
Primary Designation Director
Industry Pharma
First Appointment 21 Apr 2008
Oldest Company Age 18 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Robins Remedies Private Limited U24100MH2009PTC192277
Director14 Aug 20092009₹2.77 Cr (FY 2024)Active
Director21 Apr 20082008Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Walden Pharmaceuticals Private Limited
Robins Remedies Private Limited
Premium access

Shareholding and investment profile for Mohandas Ramakrishnan Kakkanat

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mohandas Ramakrishnan Kakkanat

Mohandas Ramakrishnan Kakkanat was first appointed on 21 Apr 2008 as Director at Walden Pharmaceuticals Private Limited. The most recent appointment on record is 14 Aug 2009 at Robins Remedies Private Limited.

Mohandas Ramakrishnan Kakkanat held 2 earlier board appointments: Robins Remedies Private Limited (Director, 14 Aug 2009 to 07 Mar 2016); Walden Pharmaceuticals Private Limited (Director, from 21 Apr 2008).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available